WallStSmart

McCormick & Company Incorporated (MKC)vsSRx Health Solutions Inc. (SRXH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

McCormick & Company Incorporated generates 55524% more annual revenue ($7.11B vs $12.78M). MKC leads profitability with a 23.1% profit margin vs 0.0%. MKC earns a higher WallStSmart Score of 80/100 (A-).

MKC

Exceptional Buy

80

out of 100

Grade: A-

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.58

SRXH

Avoid

19

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 4.0
Piotroski: 2/9Altman Z: -6.89
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKCUndervalued (+25.2%)

Margin of Safety

+25.2%

Fair Value

$94.33

Current Price

$47.24

$47.09 discount

UndervaluedFair: $94.33Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKC6 strengths · Avg: 9.0/10
P/E RatioValuation
8.0x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
528.0%10/10

Earnings expanding 528.0% YoY

Return on EquityProfitability
23.5%9/10

Every $100 of equity generates 24 in profit

Profit MarginProfitability
23.1%9/10

Keeps 23 of every $100 in revenue as profit

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
16.7%8/10

16.7% revenue growth

SRXH0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

MKC2 concerns · Avg: 4.0/10
PEG RatioValuation
1.884/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.584/10

Distress zone — elevated risk

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$70.24M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.243/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MKC

The strongest argument for MKC centers on P/E Ratio, EPS Growth, Return on Equity. Profitability is solid with margins at 23.1% and operating margin at 14.3%. Revenue growth of 16.7% demonstrates continued momentum.

Bull Case : SRXH

SRXH has a balanced fundamental profile.

Bear Case : MKC

The primary concerns for MKC are PEG Ratio, Altman Z-Score.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

MKC profiles as a growth stock while SRXH is a value play — different risk/reward profiles.

MKC is growing revenue faster at 16.7% — sustainability is the question.

MKC generates stronger free cash flow (18M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKC scores higher overall (80/100 vs 19/100), backed by strong 23.1% margins and 16.7% revenue growth. Both earn "Exceptional Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

McCormick & Company Incorporated

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?